Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis.

MLA

Jia, Na, et al. “Influence of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on the Risk of All‐cause Mortality and Other Clinical Outcomes in Patients with Confirmed COVID‐19: A Systemic Review and Meta‐analysis.” Journal of Clinical Hypertension, vol. 23, no. 9, Sept. 2021, pp. 1651–63. EBSCOhost, https://doi.org/10.1111/jch.14329.

APA

Jia, N., Zhang, G., Sun, X., Wang, Y., Zhao, S., Chi, W., Dong, S., Xia, J., Zeng, P., & Liu, D. (2021). Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis. Journal of Clinical Hypertension, 23(9), 1651–1663. https://doi.org/10.1111/jch.14329

Chicago

Jia, Na, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng, and Deping Liu. 2021. “Influence of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on the Risk of All‐cause Mortality and Other Clinical Outcomes in Patients with Confirmed COVID‐19: A Systemic Review and Meta‐analysis.” Journal of Clinical Hypertension 23 (9): 1651–63. doi:10.1111/jch.14329.